The efficacy of fibronectin eye drops on non-healed corneal epithelial disorders
Not Applicable
Completed
- Conditions
- non-healed corneal epithelial disorders
- Registration Number
- JPRN-UMIN000025299
- Lead Sponsor
- Ohshima Eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Women who is pregnant or might be pregnant Breast feeding Hypersensitivity to eye drops Pts who are not adequate to enroll
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wound healing speed of corneal epithelial defect for 4 weeks Duration for complete closure of corneal epithelial defect
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fibronectin's effect on corneal epithelial healing?
How does fibronectin eye drop efficacy compare to traditional treatments for non-healed corneal epithelial disorders?
Are there specific biomarkers that correlate with response to fibronectin therapy in corneal epithelial disorders?
What adverse events are associated with fibronectin eye drops in clinical trials for corneal healing?
What are the potential combination therapies involving fibronectin for treating non-healed corneal epithelial disorders?